Published in Eur J Epidemiol on September 01, 1999
Multidrug-resistant tuberculosis in prison inmates, Azerbaijan. Emerg Infect Dis (2001) 1.75
An unanswered health disparity: tuberculosis among correctional inmates, 1993 through 2003. Am J Public Health (2005) 1.57
Comparison of a new ESAT-6/CFP-10 peptide-based gamma interferon assay and a tuberculin skin test for tuberculosis screening in a moderate-risk population. Clin Vaccine Immunol (2006) 1.16
The booster effect in two-step tuberculin testing among young adults in Montreal. Ann Intern Med (1994) 3.75
Increasing incidence of tuberculosis in a prison inmate population. Association with HIV infection. JAMA (1989) 3.67
Association of tuberculosis infection with increased time in or admission to the New York City jail system. JAMA (1993) 2.67
Increased rate of tuberculin skin test conversion among workers at a university hospital. Infect Control Hosp Epidemiol (1992) 2.60
Multidrug-resistant tuberculosis in the New York State prison system, 1990-1991. J Infect Dis (1994) 2.45
Undetected tuberculosis in prison. Source of infection for community at large. JAMA (1978) 2.44
Tuberculosis transmission in a large urban jail. JAMA (1977) 2.11
Impact of tuberculosis control measures and crowding on the incidence of tuberculous infection in Maryland prisons. Clin Infect Dis (1997) 1.29
Transmission of multidrug-resistant tuberculosis among immunocompromised persons in a correctional system--New York, 1991. MMWR Morb Mortal Wkly Rep (1992) 1.25
Probable transmission of multidrug-resistant tuberculosis in a correctional facility--California. MMWR Morb Mortal Wkly Rep (1993) 1.14
Choosing an appropriate cutting point for conversion in annual tuberculin skin testing. Am Rev Respir Dis (1985) 1.12
Tuberculin skin test conversion in hospital employees vaccinated with bacille Calmette-Guérin: recent Mycobacterium tuberculosis infection or booster effect? Am J Infect Control (1995) 1.11
Results of a 29-state survey of tuberculosis in nursing homes and correctional facilities. Public Health Rep (1993) 1.10
Tuberculin conversions: true or false? Am Rev Respir Dis (1978) 1.06
Tuberculosis surveillance in a state prison system. Am J Public Health (1989) 0.92
Tuberculin conversions in Indochinese refugees. An assessment of boosting and anergy. Am Rev Respir Dis (1985) 0.85
Tuberculin test conversion during repeated skin testing, associated with sensitivity to nontuberculous mycobacteria. Am Rev Respir Dis (1979) 0.85
High rate of tuberculin conversion in Indochinese refugees. JAMA (1982) 0.85
Tuberculosis contact investigation: two years of experience in New York City correctional facilities. Am J Infect Control (1993) 0.76
Tuberculin skin-test conversions among Indochinese refugees--Monroe County, New York. MMWR Morb Mortal Wkly Rep (1981) 0.75
Two-stage tuberculin skin testing in individuals with human immunodeficiency virus infection. Community Programs for Clinical Research on AIDS. Am J Respir Crit Care Med (1995) 0.75
Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopathol (1997) 5.94
"Sick of Smoking": evaluation of a targeted minimal smoking cessation intervention in general practice. Med J Aust (1990) 4.11
Dementia in AIDS patients: incidence and risk factors. Multicenter AIDS Cohort Study. Neurology (1993) 3.53
Molecular and geographic patterns of tuberculosis transmission after 15 years of directly observed therapy. JAMA (1998) 3.07
3-5 year longitudinal follow-up of pediatric patients after acute renal failure. Kidney Int (2006) 3.03
Rumors of disease in the global village: outbreak verification. Emerg Infect Dis (2000) 2.95
Effect of Mycobacterium tuberculosis on HIV replication. Role of immune activation. J Immunol (1996) 2.86
Voluntary testing for human immunodeficiency virus (HIV) in a prison population with a high prevalence of HIV. Am J Epidemiol (1994) 2.81
Time to initiation of anti-tuberculosis treatment. Tuber Lung Dis (1996) 2.53
Antibody responses to Haemophilus influenzae type B vaccines in men with human immunodeficiency virus infection. N Engl J Med (1991) 2.46
Potential factors affecting adherence with HIV therapy. AIDS (1997) 2.44
Vitamin A deficiency and wasting as predictors of mortality in human immunodeficiency virus-infected injection drug users. J Infect Dis (1995) 2.25
Trends in infectious disease mortality in Australia, 1979-1994. Med J Aust (1998) 2.02
Prevalence and incidence of hepatitis C virus infection among male prison inmates in Maryland. Eur J Epidemiol (1993) 1.73
A randomized trial of a problem-based learning approach for teaching epidemiology. Acad Med (2001) 1.68
Prophylactic efficacy of intranasal alpha 2-interferon against rhinovirus infections in the family setting. N Engl J Med (1986) 1.67
A review of Q fever in Australia 1991-1994. Aust N Z J Public Health (1997) 1.67
HIV risk behaviors and their relationship to posttraumatic stress disorder among women prisoners. Psychiatr Serv (2001) 1.67
Effect of CD4+ cell count measurement variability on staging HIV-1 infection. J Acquir Immune Defic Syndr (1992) 1.65
Health services use by urban women with or at risk for HIV-1 infection: the HIV Epidemiology Research Study (HERS). J Acquir Immune Defic Syndr Hum Retrovirol (1998) 1.61
Bacterial pneumonia in adult populations with human immunodeficiency virus (HIV) infection. Am J Epidemiol (1993) 1.59
Comparison of a tuberculin interferon-gamma assay with the tuberculin skin test in high-risk adults: effect of human immunodeficiency virus infection. J Infect Dis (1997) 1.54
South Australian hypertension survey. General practitioner knowledge and reported management practices--a cause for concern? Med J Aust (1992) 1.49
Acute respiratory illness in Adelaide children--the influence of child care. Med J Aust (1991) 1.45
The incidence of hepatitis B infection in Australia: an epidemiological review. Med J Aust (1996) 1.41
Missed opportunities for prevention of tuberculosis in Victoria, Australia. Int J Tuberc Lung Dis (1997) 1.40
Australian doctors' beliefs and practice regarding Helicobacter pylori. Med J Aust (1999) 1.39
Increased mortality associated with vitamin A deficiency during human immunodeficiency virus type 1 infection. Arch Intern Med (1993) 1.39
Changes in bed resources and admission patterns in acute public hospitals in Victoria, 1987-1995. Med J Aust (1997) 1.38
Stress and acute respiratory infection. Am J Epidemiol (1986) 1.36
Transmission of Mycobacterium tuberculosis by a fiberoptic bronchoscope. Identification by DNA fingerprinting. JAMA (1997) 1.30
Zidovudine and stavudine sequencing in HIV treatment planning: findings from the CHORUS HIV cohort. J Acquir Immune Defic Syndr (2001) 1.29
Impact of tuberculosis control measures and crowding on the incidence of tuberculous infection in Maryland prisons. Clin Infect Dis (1997) 1.29
Dietary micronutrient intake and risk of progression to acquired immunodeficiency syndrome (AIDS) in human immunodeficiency virus type 1 (HIV-1)-infected homosexual men. Am J Epidemiol (1993) 1.23
Effects of micronutrient intake on survival in human immunodeficiency virus type 1 infection. Am J Epidemiol (1996) 1.21
Use of antiherpes drugs and the risk of Kaposi's sarcoma: data from the Multicenter AIDS Cohort Study. J Infect Dis (1996) 1.20
Tuberculin reactivity and the risk of tuberculosis: a review. Int J Tuberc Lung Dis (2000) 1.20
Association between serum vitamin A and E levels and HIV-1 disease progression. AIDS (1997) 1.19
Interaction of socioeconomic status and provider practices as predictors of immunization coverage in Virginia children. Pediatrics (1995) 1.19
Weight loss prior to clinical AIDS as a predictor of survival. Multicenter AIDS Cohort Study Investigators. J Acquir Immune Defic Syndr Hum Retrovirol (1995) 1.19
Drug smoking, Pneumocystis carinii pneumonia, and immunosuppression increase risk of bacterial pneumonia in human immunodeficiency virus-seropositive injection drug users. Am J Respir Crit Care Med (1994) 1.17
Does smoking explain sex differences in the global tuberculosis epidemic? Epidemiol Infect (2006) 1.15
Acute respiratory illness in Adelaide children: breast feeding modifies the effect of passive smoking. J Epidemiol Community Health (1990) 1.14
Isoniazid preventive therapy, hepatitis C virus infection, and hepatotoxicity among injection drug users infected with Mycobacterium tuberculosis. Clin Infect Dis (2001) 1.13
High rate of transmission of tuberculosis in an office: impact of delayed diagnosis. Clin Infect Dis (1995) 1.12
Histologic development of cervical ectopy: relationship to reproductive hormones. Sex Transm Dis (2000) 1.09
Heterogeneity in the spatial distribution of bacterial sexually transmitted infections. Sex Transm Infect (2008) 1.08
Changes in markers of disease progression in HIV-1 seroconverters: a comparison between cohorts of injecting drug users and homosexual men. J Acquir Immune Defic Syndr Hum Retrovirol (1995) 1.07
Low serum vitamin B-12 concentrations are associated with faster human immunodeficiency virus type 1 (HIV-1) disease progression. J Nutr (1997) 1.07
The influence of drug use patterns on the rate of CD4+ lymphocyte decline among HIV-1-infected injecting drug users. AIDS (1997) 1.04
Comparison of self-reported injection frequencies for past 30 days and 6 months among intravenous drug users. J Clin Epidemiol (1994) 1.02
Relationship of hormonal contraception and cervical ectopy as measured by computerized planimetry to chlamydial infection in adolescents. Sex Transm Dis (2000) 1.02
Tuberculosis treatment delivery in Bali: a qualitative study of clinic staff perceptions. Int J Tuberc Lung Dis (2004) 1.02
Serum hormones in men with human immunodeficiency virus-associated wasting. J Clin Endocrinol Metab (1996) 1.02
Compliance with universal precautions in correctional health care facilities. J Occup Environ Med (1999) 1.01
Incidence and prevalence of hepatitis C among clients of a Brisbane methadone clinic: factors influencing hepatitis C serostatus. Aust N Z J Public Health (1997) 1.01
Instability of delayed-type hypersensitivity skin test anergy in human immunodeficiency virus infection. Arch Intern Med (1995) 0.99
The effect of the interaction of acyclovir with zidovudine on progression to AIDS and survival. Analysis of data in the Multicenter AIDS Cohort Study. Ann Intern Med (1994) 0.98
Correlation between self-reported adherence to highly active antiretroviral therapy (HAART) and virologic outcome. Adv Ther (2001) 0.97
Comparison between a whole blood interferon-gamma release assay and tuberculin skin testing for the detection of tuberculosis infection among patients at risk for tuberculosis exposure. J Infect Dis (1999) 0.95
Predicting tuberculosis among migrant groups. Epidemiol Infect (2002) 0.95
Impact of immunosuppression on health care use by men in the Multicenter AIDS Cohort Study (MACS). J Acquir Immune Defic Syndr (1994) 0.95
A syphilis outbreak in remote Australia: epidemiology and strategies for control. Epidemiol Infect (2004) 0.95
Brief report: rifampin-resistant tuberculosis in a patient receiving rifabutin prophylaxis. N Engl J Med (1996) 0.94
South Australian hypertension survey. General practitioner experiences with drug treatment. Med J Aust (1992) 0.94
Impact of policy and practice on the effectiveness of contact screening for tuberculosis. Prev Med (1999) 0.93
A large outbreak of conjunctivitis caused by a single genotype of Neisseria gonorrhoeae distinct from those causing genital tract infections. Epidemiol Infect (2001) 0.93
The importance of glucose in the oxidative metabolism of the pregnant uterus and its contents in conscious sheep with some preliminary observations on the oxidation of fructose and glucose by fetal sheep. Q J Exp Physiol Cogn Med Sci (1972) 0.93
Tuberculosis rates among migrants in Australia and Canada. Int J Tuberc Lung Dis (2002) 0.92
Cervical ectopy and the transformation zone measured by computerized planimetry in adolescents. Int J Gynaecol Obstet (1999) 0.91
Immunization coverage in a population-based sample of Maryland children. Arch Pediatr Adolesc Med (1994) 0.91
An epidemiologic analysis of Mycobacterium avium complex disease in homosexual men infected with human immunodeficiency virus type 1. Clin Infect Dis (1995) 0.90
Dietary intake of community-based HIV-1 seropositive and seronegative injecting drug users. Nutrition (1997) 0.88
Development of a Vietnamese version of the Short form-36 Health Survey. Asia Pac J Public Health (2000) 0.88
Long-term survival without clinical AIDS after CD4+ cell counts fall below 200 x 10(6)/l. AIDS (1995) 0.88
The effect of latent Mycobacterium tuberculosis infection on human immunodeficiency virus (HIV) disease progression and HIV RNA load among injecting drug users. J Infect Dis (1996) 0.86
Longitudinal incidence of tuberculosis in South-East Asian refugees after re-settlement. Int J Tuberc Lung Dis (1999) 0.86
Epidemiologic patterns of upper respiratory illness and Pneumocystis carinii pneumonia in homosexual men. Am Rev Respir Dis (1991) 0.85
The cost-effectiveness of evidence-based guidelines and practice for screening and prevention of tuberculosis. Health Econ (2000) 0.85
Supplemental vitamin B and progression to AIDS and death in black South African patients infected with HIV. J Acquir Immune Defic Syndr (1999) 0.84
Effect of chronic substance abuse on the neuropsychological performance of intravenous drug users with a high prevalence of HIV-1 seropositivity. Am J Epidemiol (1992) 0.84
Preventability of incident cases of tuberculosis in recently exposed contacts. Int J Tuberc Lung Dis (1998) 0.84
The contribution of community health surveys to aboriginal health in the 1990s. Aust N Z J Public Health (1998) 0.84
Seating of ceramic liners in the uncemented trident acetabular shell: is there really a problem? Clin Orthop Relat Res (2009) 0.83
Influenza vaccination in Victoria, 1992. Med J Aust (1993) 0.83
Has access to hospital improved for Aborigines in the northern territory? Aust N Z J Public Health (1996) 0.83
Shifting the balance between in-patient and out-patient care for tuberculosis results in economic savings. Int J Tuberc Lung Dis (2001) 0.83
Lack of association between seropositivity to Chlamydia pneumoniae and carotid atherosclerosis. Am J Cardiol (1999) 0.82
Barriers to immunisation in general practice. Aust N Z J Public Health (1999) 0.82
Virologic, immunologic, and immune activation markers as predictors of HIV-associated weight loss prior to AIDS. Multicenter AIDS Cohort Study. J Acquir Immune Defic Syndr (1999) 0.81
The prevalence of markers of infection with hepatitis B virus in a mixed-race Australian community. Med J Aust (1989) 0.81
The drug use behaviour of cocaine users. Drug Alcohol Rev (1990) 0.80
Serum antibodies to HIV-1 are produced post-measles virus infection: evidence for cross-reactivity with HLA. Clin Exp Immunol (1998) 0.79
Middle-ear disease in remote Aboriginal Australia: a field assessment of surgical outcomes. J Laryngol Otol (2000) 0.79